Showing results (1061-1070 of 1,141) with videos related to

Sort By:
Pageof 115
European Heart Journal|January 5, 2019
Transcatheter heart valve interventions: where are we? Where are we going?Bernard D Prendergast, Helmut Baumgartner, Victoria Delgado, et al.
Molecular Oncology|March 18, 2021
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarksSebastian Kehrloesser, Simon Oberst, Willien Westerhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2020
Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory SyndromeSeher Anjum, Owen Dean, Peter Kosa, et al.
Der Urologe. Ausg. A|November 16, 2016
[MRI/TRUS fusion-guided prostate biopsy : Value in the context of focal therapy]T Franz, J von Hardenberg, A Blana, et al.
Neuro-Oncology|February 4, 2026
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine gliomaAndrea Timpanaro, Edward Z Song, Ryma Toumi, et al.
Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine gliomaAndrea Timpanaro, Edward Z Song, Ryma Toumi, et al.
BMC Cancer|August 18, 2023
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trialLisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastomaNavin Pinto, Annette Künkele, Catherine M Albert, et al.
Pageof 115